Thrive Earlier Detection Corp lands $257m Series B

Cambridge, Massachusetts and Baltimore-based Thrive Earlier Detection Corp, a healthcare company focused on incorporating earlier cancer detection into routine medical care, has raised $257 million in Series B financing.

Cambridge, Massachusetts and Baltimore-based Thrive Earlier Detection Corp, a healthcare company focused on incorporating earlier cancer detection into routine medical care, has raised $257 million in Series B financing. Casdin Capital and Section 32 led the round with participation from other investors that included Bain Capital Life Sciences, Brown Advisory, Driehaus Capital Management, Intermountain Ventures, Janus Henderson Investors, Lux Capital, Moore Strategic Ventures, Perceptive Advisors, Rock Springs Capital, Sands Capital and funds and accounts advised by T. Rowe Price Associates Inc.

Source: Press Release